BioSpace News Archive

BioMidwest

NovAccess Global to Participate in National Brain Tumor Society’s Annual Glioblastoma Awareness Day

NovAccess Global Inc. today announced that its Chief Executive Officer Dr. Dwain K. Irvin will be participating in the National Brain Tumor Society’s (NBTS) fifth annual Glioblastoma Awareness Day on July 19, 2023 in support of the fight against one of the fastest growing and aggressive brain tumors.

July 13, 2023
·
5 min read
Genetown

RedShift BioAnalytics Announces Launch of Aurora Second-Generation MMS Platform, for Ultra-Sensitive Biophysical Characterization of Biomolecules

RedShift BioAnalytics announces the launch of Aurora, the company’s latest system using ground-breaking MMS technology.

July 13, 2023
·
3 min read
Pharm Country

Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading

Quest Diagnostics today announced the launch of a novel prostate cancer biomarker test through its subspecialty pathology business, AmeriPath, in collaboration with Envision Sciences.

July 13, 2023
·
5 min read
Genetown

Cumulus Neuroscience Announces Research Collaboration with the Universities of Bath and Bristol on Development of Breakthrough Test for Early Detection of Alzheimer’s Dementia

Cumulus Neuroscience (Cumulus; The Company) today announced a major research collaboration with the Universities of Bath and Bristol on development of the Fastball electroencephalogram (EEG) test, an innovative diagnostic test for earlier detection of Alzheimer’s Dementia (AD).

July 13, 2023
·
6 min read
Pharm Country

Virpax Pharmaceuticals Files Provisional Patent Application for Intranasal Delivery

Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX) today announced that it has filed a new provisional patent application with the United States Patent and Trademark Office (‘USPTO’) entitled “Intranasal Delivery” related to its Envelta™ product candidate.

July 13, 2023
·
5 min read
BioMidwest

Co-Diagnostics, Inc. Awarded Funding for Co-Dx PCR Home Platform from NIH RADx® Tech Program

Co-Diagnostics, Inc. announced that it has been awarded $1.2 million in funding from the National Institutes of Health as part of the Rapid Acceleration of Diagnostics Tech program for completion of its upcoming upper respiratory panel on the Company’s Co-Dx PCR Home™ testing platform.

July 13, 2023
·
4 min read
Medexus Announces Preliminary Revenue for Fiscal Q1 2024

Preliminary estimates indicate revenue is expected to exceed US$31 million for fiscal quarter ended June 30, 2023

July 13, 2023
·
4 min read
BioMidwest

Evren Technologies Announces Launch of Revolutionary Phoenix®100 System for Vagus Nerve Stimulation Research

Evren Technologies announced the launch of its pioneering Phoenix® 100 System, a state-of-the-art transcutaneous auricular vagus nerve stimulator research tool.

July 13, 2023
·
3 min read
Pharm Country

Study Proves iTind Treatment for Enlarged Prostate Lasts More than Four Years

Olympus Corporation, a global medical technology company, announced publication of study data demonstrating that the minimally invasive iTind™ treatment provides long-lasting relief of more than four years for people suffering from the symptoms of an enlarged prostate, also known as BPH.

July 13, 2023
·
6 min read
Genetown

Quest Diagnostics Employees Support Healthy NewsWorks Student Journalists

On May 23, several Quest Diagnostics employees volunteered at the Healthy NewsWorks Spring Celebration, featuring achievements of its student reporters from the greater Philadelphia area.

July 13, 2023
·
2 min read